A detailed history of Somerset Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Somerset Trust CO holds 6,213 shares of MRK stock, worth $781,906. This represents 0.34% of its overall portfolio holdings.

Number of Shares
6,213
Previous 5,572 11.5%
Holding current value
$781,906
Previous $607,000 34.93%
% of portfolio
0.34%
Previous 0.27%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

BUY
$113.24 - $131.95 $72,586 - $84,579
641 Added 11.5%
6,213 $819,000
Q4 2023

Jan 08, 2024

BUY
$100.18 - $109.02 $114,806 - $124,936
1,146 Added 25.89%
5,572 $607,000
Q3 2023

Oct 17, 2023

SELL
$102.95 - $114.33 $30,164 - $33,498
-293 Reduced 6.21%
4,426 $455,000
Q2 2023

Jul 07, 2023

SELL
$108.61 - $118.38 $49,200 - $53,626
-453 Reduced 8.76%
4,719 $544,000
Q1 2023

Apr 05, 2023

SELL
$102.94 - $114.86 $105,925 - $118,190
-1,029 Reduced 16.59%
5,172 $550,000
Q4 2022

Jan 03, 2023

BUY
$87.44 - $112.11 $64,705 - $82,961
740 Added 13.55%
6,201 $688,000
Q3 2022

Oct 03, 2022

BUY
$84.53 - $94.96 $3,972 - $4,463
47 Added 0.87%
5,461 $470,000
Q2 2022

Jul 06, 2022

BUY
$83.49 - $94.64 $20,455 - $23,186
245 Added 4.74%
5,414 $494,000
Q1 2022

Apr 05, 2022

BUY
$73.51 - $82.4 $21,611 - $24,225
294 Added 6.03%
5,169 $424,000
Q4 2021

Jan 07, 2022

BUY
$72.28 - $90.54 $5,637 - $7,062
78 Added 1.63%
4,875 $374,000
Q3 2021

Oct 07, 2021

BUY
$71.68 - $78.83 $343,848 - $378,147
4,797 New
4,797 $360,000
Q2 2019

Jul 31, 2019

SELL
$69.84 - $81.59 $48,818 - $57,031
-699 Closed
0 $0
Q1 2019

Apr 09, 2019

BUY
$69.58 - $79.36 $36,807 - $41,981
529 Added 311.18%
699 $58,000
Q4 2018

Jan 22, 2019

BUY
$65.24 - $75.71 $9,525 - $11,053
146 Added 608.33%
170 $13,000
Q3 2018

Oct 15, 2018

BUY
$57.69 - $67.84 $1,384 - $1,628
24 New
24 $2,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Somerset Trust CO Portfolio

Follow Somerset Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerset Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Somerset Trust CO with notifications on news.